The stent struts of the Biotronik Orsiro stent.
News | Stents | December 21, 2020
New Stent Kink Resistance Testing Proposed in ASTM International Standard
December 21, 2020 – A proposed ASTM International standard will answer the need for a standardized test method that...
read more
HeartMate 3 heart pump is now approved for use for pediatric patients battling advanced heart failure offering a new treatment option for this underserved population
News | Heart Failure | December 21, 2020
FDA Approves Abbott's HeartMate 3 VAD for Pediatric Patients
December 21, 2020 — U.S. Food and Drug Administration (FDA) approved updated labeling December 17 for Abbott's...
read more
AI Medic Inc. has obtained official product certification from the NIDS for its own medical video analysis software, AutoSEG
News | December 16, 2020
AI Fully Automates Cardiac CT Image 3-D Analysis
December 16, 2020 — AI Medic Inc. announced that it has obtained official product certification from the NIDS (National...
read more
A peripheral artery disease (PAD) patient CT scan showing blockages in the femoral arteries in the legs with collateral flow in the leg on the right.

A peripheral artery disease (PAD) patient CT scan showing blockages in the femoral arteries in the legs with collateral flow in the leg on the right.

News | Stents Bioresorbable | December 16, 2020
First-In-Human Use Reported for Bioresorbable Efemoral Vascular Scaffold System
December 16, 2020 — Efemoral Medical announced the first-in-human (FIH) use of the its Efemoral bioresorbable vascular...
read more
Corpath GRX interventional cardiology robotic system is comprised of two different components: 1. The control console. 2. The bedside unit.

Corpath GRX interventional cardiology robotic system is comprised of two different components: 1. The control console. 2. The bedside unit.

News | Robotic Systems | December 16, 2020
Corindus Launches technIQ 1 Smart Procedural Automation Series for CorPath GRX Cath lab Robotic System
December 16, 2020 — Corindus, A Siemens Healthineers company and a leading developer of vascular robotics, began its...
read more
The Digisonics' cardiovascular information system (CVIS) system.
News | Cardiovascular Information Systems (CVIS) | December 16, 2020
Intelerad Acquires Digisonics to Expand its Enterprise Imaging Workflow 
December 16, 2020 - Intelerad Medical Systems, a provider of enterprise imaging workflow solutions, has acquired...
read more
Videos | FFR Technologies | December 16, 2020
VIDEO: Example of the Medis QFR Angiography Image Derived FFR System
This is an example of the Medis Medical Imaging Quantitative Flow Ratio (QFR) system that offers a fractional flow...
read more
Videos | Robotic Systems | December 16, 2020
VIDEO: Corindus CorPath Robotic PCI System For The Cardiac Cath Lab
This is an example of the Siemens Corindus CorPath Cath lab robotic system being used for a percutaneous coronary...
read more
The Medis Quantitative Flow Ratio (QFR) is a novel, non-invasive, angiography-based physiologic FFR-like assessment of the presence and extent of coronary artery disease.

The Medis Quantitative Flow Ratio (QFR) is a novel, non-invasive, angiography-based physiologic FFR-like assessment of the presence and extent of coronary artery disease. 

News | FFR Technologies | December 16, 2020
Acist Medical Partners With Medis to Distribute Angiography Image Derived FFR Quantification System
December 16, 2020 – Acist Medical Systems Inc. announced a formal distribution partnership with Medis Medical Imaging...
read more
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist
Feature | Wearables | December 15, 2020
Cardiac Monitoring in the Time of COVID-19: Next Generation Wearable ECG Technology Comes into Its Own
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office...
read more
Webinar | Information Technology | December 15, 2020
WEBINAR: Understanding the Benefits of Single-Database Cardiology
To improve efficiencies in your cardiology department, you need technology to streamline workflows, reduce redundant...
read more
Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) so the company to initiate a U.S. clinical study of its Tria biopolymer mitral surgical heart valve.
News | Heart Valve Technology | December 14, 2020
Foldax to Initiate FDA Clinical Study of Biopolymer Mitral Heart Valve
December 14, 2020 - Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an...
read more
The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec, 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance.  #COVID #COVID19 #SARSCoV2 #vaccine #COVIDVaccine

The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec. 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance. 

Feature | Coronavirus (COVID-19) | December 14, 2020 | Dave Fornell, Editor
FDA Clears First COVID-19 Vaccine Under an Emergency Use Authorization
December 14, 2020 — The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for...
read more
SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). The  TIVUS System for renal artery denervation treats resistant hypertension, which is defined as blood pressure that remains above 140/90 mmHg despite use of three antihypertensive medications of different classes at the best tolerated doses.

SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).

News | Renal Denervation | December 09, 2020
FDA Grants Breakthrough Device Designation for the TIVUS Renal Artery Denervation System
December 9, 2020 — SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to...
read more
Videos | Coronavirus (COVID-19) | December 07, 2020
VIDEO: What Are The Long-term Cardiac Impacts of COVID-19 Infection
Todd Hurst, M.D., a cardiologist at Banner University Medicine Heart Institute, and an associate professor at the...
read more
© Copyright Wainscot Media. All Rights Reserved.